Contact Us
Find A Doctor

Serial Retinal Thickness Changes Clinical Trial

Enrollment Status

Open Enrollment

Objective

To evaluate the efficacy of intravitreal bevasiranib sodium as maintenance therapy for Age-Related Macular Degeneration following initiation of anti-VEGF therapy with 3 doses of Lucentis®

 

 

 

Contact Us

Dr. Richard Rosen, Principal InvestigatorTel: (212) 979-4284

Melissa Rivas, Research CoordinatorTel: (212) 614-8386

Address310 E. 14th StreetNew York, NY 10003

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locations